OPKO Health, Inc. (NASDAQ:OPK) has market worth of 1.78B along 584.90M outstanding shares. The stock moved 0.00% to $3.04 in recent session. The recent traded volume was 1800793 shares. The stock is valued at $3.04 in current session.
Many Insiders have done trades inside OPKO Health, Inc. (NASDAQ:OPK). The Company has disclosed insider trading transaction to the Securities and Exchange Commission (SEC). The Fishel Robert Scott; Director of OPKO Health, Inc. acquired 12500 shares at value of $2.97 on 25 Apr 2018. The Insider selling transaction had a total value worth of $37125. After the buying activity, now Fishel Robert Scott directly owns 4048928 shares of the company’s stock, valued at approximately $12308741.12. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing on 26 Apr 2018.
OPKO Health, Inc.’s insider FROST PHILLIP MD ET AL purchased 55372 shares of the stock in a negotiation that occurred on 25 Apr 2018. The stock was bought at an average cost of S 2.99 per share, for a total transaction worth of $ 165342. The Buy was disclosed in a legal filing with the Securities & Exchange Commission, on 26 Apr 2018.
In related news, FROST PHILLIP MD ET AL CEO & Chairman bought 75000 shares of the firm’s stock in a transaction that recorded on 24 Apr 2018. The stock was bought at an average price of $ 2.97 for a total value of $ 222641. After the negotiation, now Insider holds 3275427 shares of the company’s stock, valued at approximately $ 9957298.08.
FROST PHILLIP MD ET AL CEO & Chairman at OPKO Health, Inc. also bought 75000 on 23 Apr 2018 at an average price of $ 3.04 for a total value of $ 227655. After the transaction, FROST PHILLIP MD ET AL owns 3200427 shares of the company’s stock, now priced at approximately $ 9729298.08. . The disclosure for this transaction can be found in SEC Form 4 submitted on 24 Apr 2018.
Additionally, FROST PHILLIP MD ET AL CEO & Chairman at the corporation bought 60000 shares for $ 187490 in a single transaction on 20 Apr 2018. Now, CEO & Chairman owns 3125427 shares worth of $ 9501298.08.
OPKO Health, Inc. (NASDAQ:OPK) has recorded a weekly performance of -5.59% and monthly performance is -8.43%. Shares have moved -37.32% over the last quarter and changed -55.75% over the recent six months. The shares registered yearly performance at -61.17% and YTD move seen at -37.96%.
In terms of profitability, OPKO Health, Inc. has a gross margin of 41.90%, an operating margin of -26.20% and a net profit margin of -28.90%. Return on assets come to -11.40% and return on investment coming to -10.60% while Return on equity come to -15.10%.